Debendox: a statement from the New Zealand Adverse Drug Reactions Committee.
D000932:Antiemetics / Q000633:toxicity*; D003509:Cyclohexanecarboxylic Acids / Q000633:toxicity*; D004025:Dicyclomine / Q000633:toxicity*; D004319:Doxylamine / Q000633:toxicity*; D004338:Drug Combinations / Q000633:toxicity; D005260:Female; D006801:Humans; D009520:New Zealand; D011247:Pregnancy; D011725:Pyridines / Q000633:toxicity*; D011736:Pyridoxine / Q000633:toxicity*
D000932:Antiemetics; D003509:Cyclohexanecarboxylic Acids; D004338:Drug Combinations; D011725:Pyridines; C004454:dicyclomine, doxylamine, pyridoxine drug combination; D004025:Dicyclomine; D004319:Doxylamine; D011736:Pyridoxine